PASITHEA THERAPEUTICS CORP. Temporary Equity, Foreign Currency Translation Adjustments
PASITHEA THERAPEUTICS CORP. (KTTA) reported Temporary Equity, Foreign Currency Translation Adjustments of -$3.99 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Shareholders' Equity
us-gaap:TemporaryEquityForeignCurrencyTranslationAdjustments · last filed 2024-03-29
- PASITHEA THERAPEUTICS CORP. temporary equity, foreign currency translation adjustments for the quarter ending 2023-12-31 was $3.06K.
- PASITHEA THERAPEUTICS CORP. temporary equity, foreign currency translation adjustments for the quarter ending 2023-09-30 was -$4.26K.
- PASITHEA THERAPEUTICS CORP. temporary equity, foreign currency translation adjustments for the quarter ending 2023-06-30 was -$317.00.
- PASITHEA THERAPEUTICS CORP. temporary equity, foreign currency translation adjustments for the quarter ending 2023-03-31 was -$2.48K.
- PASITHEA THERAPEUTICS CORP. temporary equity, foreign currency translation adjustments for fiscal 2023 was -$3.99K, a 140.31% decline from fiscal 2022.
- PASITHEA THERAPEUTICS CORP. temporary equity, foreign currency translation adjustments for fiscal 2022 was $9.90K.
| Period end | Temporary Equity, Foreign Currency Translation Adjustments 3 month | Temporary Equity, Foreign Currency Translation Adjustments 6 month | Temporary Equity, Foreign Currency Translation Adjustments 9 month | Temporary Equity, Foreign Currency Translation Adjustments 12 month |
|---|---|---|---|---|
| 2023-12-31 | $3.06K derived: 10-K 12 month − 3 quarters · filed 2024-03-29 | -$1.19K derived: sum of 2 quarters · filed 2024-03-29 | -$1.51K derived: sum of 3 quarters · filed 2024-03-29 | -$3.99K 10-K · filed 2024-03-29 |
| 2023-09-30 | -$4.26K 10-Q · filed 2023-11-13 | -$4.57K derived: sum of 2 quarters · filed 2023-11-13 | -$7.06K derived: sum of 3 quarters · filed 2023-11-13 | |
| 2023-06-30 | -$317.00 10-Q · filed 2023-11-13 | -$2.80K derived: sum of 2 quarters · filed 2023-11-13 | ||
| 2023-03-31 | -$2.48K 10-Q · filed 2023-11-13 | |||
| 2022-12-31 | $9.90K 10-K · filed 2024-03-29 | |||
| 2022-09-30 | -$82.51K 10-Q · filed 2023-11-13 | -$131.50K derived: sum of 2 quarters · filed 2023-11-13 | -$136.01K derived: sum of 3 quarters · filed 2023-11-13 | |
| 2022-06-30 | -$48.98K 10-Q · filed 2023-11-13 | -$53.50K derived: sum of 2 quarters · filed 2023-11-13 | ||
| 2022-03-31 | -$4.51K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |